Brief: Longeveron® Announces Completion Of Successful Investigator Meeting For On-Going Phase 2B Clinical Trial Evaluating Lomecel-B™ As A Potential Treatment For HLHS, A Rare Pediatric Cardiac Disease
11/06/2024 14:17
June 11 (Reuters) - Longeveron Inc LGVN.O :
* LONGEVERON® ANNOUNCES COMPLETION OF SUCCESSFUL
INVESTIGATOR
MEETING FOR ON-GOING PHASE 2B CLINICAL TRIAL EVALUATING
LOMECEL-B™ AS A POTENTIAL TREATMENT FOR HLHS, A RARE PEDIATRIC
CARDIAC DISEASE
* LONGEVERON® ANNOUNCES COMPLETION OF SUCCESSFUL
INVESTIGATOR
MEETING FOR ON-GOING PHASE 2B CLINICAL TRIAL EVALUATING
LOMECEL-B™ AS A POTENTIAL TREATMENT FOR HLHS, A RARE PEDIATRIC
CARDIAC DISEASE
* LONGEVERON INC - ELPIS II PHASE 2B CLINICAL TRIAL ON TRACK
FOR
COMPLETING ENROLLMENT BY END OF 2024
Source text for Eikon: ID:nGNX9sP2fB
Further company coverage: LGVN.O
((Reuters.Briefs@thomsonreuters.com;))